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Primary progressive aphasias (PPA) are neurodegenerative diseases clinically
characterized by an early and relatively isolated language impairment. Three main
clinical variants, namely the nonfluent/agrammatic variant (nfvPPA), the semantic
variant (svPPA), and the logopenic variant (lvPPA) have been described, each with
specific linguistic/cognitive deficits, corresponding anatomical and most probable
pathological features. Since the discovery and the development of diagnostic criteria for
the PPA variants by the experts in the field, significant progress has been made in the
understanding of these diseases. This review aims to provide an overview of the literature
on each of the PPA variant in terms of their clinical, anatomical and pathological features,
with a specific focus on recent findings. In terms of clinical advancements, recent
studies have allowed a better characterization and differentiation of PPA patients based
on both their linguistic and non-linguistic profiles. In terms of neuroimaging, techniques
such as diffusion imaging and resting-state fMRI have allowed a deeper understanding
of the impact of PPA on structural and functional connectivity alterations beyond the
well-defined pattern of regional gray matter atrophy. Finally, in terms of pathology,
despite significant advances, clinico-pathological correspondence in PPA remains far
from absolute. Nonetheless, the improved characterization of PPA has the potential to
have a positive impact on the management of patients. Improved reliability of diagnoses
and the development of reliable in vivo biomarkers for underlying neuropathology will
also be increasingly important in the future as trials for etiology-specific treatments
become available.
Keywords: primary progressive aphasia, nonfluent/agrammatic variant, semantic variant, logopenic variant,
language, brain connectivity
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INTRODUCTION
In 1892, Arnold Pick (1) first described a patient with a clinical
history of progressive and isolated language deficits, along with
mild memory impairment and progressive social dysfunction.
Around the same time, Paul Sérieux (2) described a woman who
presented with a progressive loss of word comprehension and in
whom, contrary to Pick’s patient, memory and intelligence were
initially preserved. When this patient died in 1897, Jules Déjerine
examined his brain, discovering neuronal loss and cortical
atrophy in bilateral temporal regions (2). More recently, Marsel
Mesulam had the opportunity to examine the cell and myelin
preparations of Sérieux’s patient, finding no evidence of either
senile plaques or neurofibrillary tangles (3). For this reason, he
considered this patient the closest prototypical example of the
syndrome now known as primary progressive aphasia (PPA).
In the modern literature, the first systematic description of a
series of PPA cases was published in 1982 byMarsel Mesulam (4).
The disorder was characterized as a “slowly progressive aphasia
without generalized dementia.” The six reported patients had
very heterogeneous linguistic profiles, which did not completely
fit the classic vascular aphasia models of Broca and Wernicke,
thus suggesting the existence of several variants of PPA.
In the mid-1970s, Warrington (5), followed by Snowden
(6), Hodges and their collaborators (7) described a progressive
disorder of semantic memory that they termed “semantic
dementia.” In 1996, Grossman (8) described a different form
of progressive language disorder, termed “progressive nonfluent
aphasia.” At the end of the 1990s, Neary and collaborators (9)
proposed a classification for frontotemporal dementia (FTD,
then used as a clinical term) that included semantic dementia
and progressive nonfluent aphasia. However, the definition of
progressive nonfluent aphasia was very broad and likely included
a variety of clinical syndromes. In 2004, a third subtype of
PPA was described by Gorno-Tempini and colleagues (10), the
“logopenic” variant of PPA (lvPPA). In 2011, an international
group of PPA investigators (11) put forth new criteria that
included these three main variants. These criteria are based on
clinical features, along with neuroimaging, neuropathological,
and genetic data, to allow homogeneous patient classification for
research purposes. In this framework, patients must first meet the
general PPA criteria proposed by Mesulam, in which a difficulty
with language must be (1) the most prominent clinical feature,
both at symptom onset and for the initial phases of the diseases,
and (2) must be the principal cause of impaired daily living
Abbreviations: AD, Alzheimer’s disease; AOS, apraxia of speech; ATAC,
argyrophilic thorny astrocyte clusters; CBD, corticobasal degeneration; CBS,
corticobasal syndrome; C9ORF72, chromosome 9 open reading frame 72; FTD,
frontotemporal dementia; GM, gray matter; lvPPA, logopenic variant primary
progressive aphasia; MAPT, microtubule-associated protein tau; MRI, magnetic
resonance imaging; nfvPPA, non-fluent/agrammatic variant primary progressive
aphasia; PET, positron emission tomography; PGRN, progranulin; PIB, Pittsburgh
Compound B; PPA, primary progressive aphasia; PPAOS, progressive apraxia of
speech; PSP, progressive supranuclear palsy; PSP-s, progressive supranuclear palsy
syndrome; SMA, supplementary motor area; svPPA, semantic variant primary
progressive aphasia; TDP-43, transactive response DNA-binding protein 43; WM,
white matter.
activities (12). The general clinical evaluation of PPA patients
aims to identify the speech-language profile, showing impaired
vs. spared speech-language skills, in order to identify the
variant. In addition to the clinical features, the diagnosis can be
further supported by neuroimaging (atrophy, hypometabolism,
hypoperfusion), and pathology. Table 1 summarizes the clinical,
anatomical, and biological features of the three main variants
of PPA.
Although these three main variants do not account for all
possible presentations of PPA, this classification is thought
to capture most patients who do not a have a genetic
form of the disease. It should be noted that, while correct
clinical characterization allows accurate prediction of anatomical
involvement, the correspondence between clinico-anatomical
and molecular findings at pathology is only probabilistic. It
reflects partially selective vulnerability of certain networks to
certain neurodegenerative diseases (13).
Since the discovery and the development of diagnosis criteria
for the PPA variants by the experts in the field in 2011, significant
progress has been made in the understanding of PPA. While
most neuroimaging studies on PPA had focused on regional
atrophy, recent neuroimaging studies have focused on the impact
of PPA on selective brain networks sustaining different language
functions. Furthermore, recent longitudinal studies have allowed
a better delineation of clinical and cerebral changes associated
with the progression of the disease. This review aims to provide
an overview and an update of the literature on each of the PPA
variant in terms of their clinical, anatomical and pathological
features. More specifically, in addition to reviewing the 2011
criteria, this review will provide an update on recent findings on
the linguistic/cognitive manifestations of the disease and on their
assessment. The latest neuroimaging studies will be reviewed
with a specific focus on disconnection aspects of the disease.
Issues and controversies associated with the diagnosis of PPA will
be discussed, and possible avenues will be examined in the light
of the most recent research.
GENERAL BACKGROUND ON
PATHOLOGY IN PPA
From a pathological point of view, each PPA variant seems
to correspond to a specific tissue pathology, and in some
cases to a gene mutation. However, the clinico-pathological
correspondence in PPA remains far from absolute, as will be
discussed more specifically for each PPA variant in the following
sections (Table 1).
One of the possible causes is the accumulation of pathological
aggregates of tau protein. Tau protein is a highly soluble
microtubule-associated protein (MAPT) and promotes
microtubule polymerization and stabilization. Disorders in
which tau pathology is considered the major contributing factor
to neurodegeneration are referred to as “primary tauopathies”
(e.g., fronto-temporal dementia tau related, FTD tau). Tau
protein in the brain is heterogeneous due to alternative splice
forms, as well as post-translational modifications, including
phosphorylation (14). The terms “3R” and “4R” tau refers to the
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TABLE 1 | Clinical, anatomical, and biological features of the three variants of PPA.
Primary progressive
aphasia variant
Clinical Anatomical Most common
pathology
Non fluent/agrammatic Effortful speech, AOS, dysarthria,
agrammatism
Left inferior frontal gyrus and
insula
FTD-4R tau
Semantic Impaired retrieval and comprehension
of low frequency single words,
semantic deficits for objects and
people, surface dyslexia/dysgraphia
Bilateral anterior temporal lobe,
usually left>right
TDP-43-C
Logopenic Word-finding difficulty, sentence
repetition/comprehension deficits and
phonological dyslexia/dysgraphia




AOS, Apraxia of speech; FTD, frontotemporal dementia; TDP-43, transactive response DNA-binding 43; AD, Alzheimer’s disease.
products of the alternative splicing of theMAPT gene, generating
tau species with either three or four conserved ∼32 amino acid
repeats in the microtubule binding domain of tau protein (15).
There is preferential accumulation of 3R or 4R tau in various
tauopathies, providing a biochemical subclassification of the
tauopathies. The MAPT gene is located on chromosome 17.
Mutations in the MAPT gene induce the formation of abnormal
normal tau protein inclusions, leading to abnormal functioning
of these cells. Changes in tau protein induced by mutations can
also decrease its effectiveness or increase its amount, which can
lead to disease.
Another frequent pathological substrate is the deposits of
transactive response DNA-binding protein 43 (TDP-43) which is
a cellular protein encoded by the TARDBP gene. Four subtypes
have been described (A, B, C, D), in some cases associated with
genes mutations. For instance, type A (TDP-43-A) is associated
in a proportion of cases with mutations in the progranulin
(PGRN or GRN) gene (16). The PGRN gene is located on
chromosome 17 and induces the production of the progranulin
protein. Mutations in the PGRN gene reduce the production of
progranulin and increase the neural aggregates of TDP-43. The
progranulin helps cell growth, and the protein TDP-43 regulates
the process of making proteins from DNA (expression). The
TARDBP gene on chromosome 1, encoding the TDP-43 protein,
is very rarely involved.
Finally, some patients (especially those with lvPPA) have an
underlying AD pathology. AD is characterized by intracellular
tau-associated neurofibrillary tangles and extracellular amyloid-β
(Aβ)–associated plaques in the brain.
VARIANTS OF PRIMARY PROGRESSIVE
APHASIA (PPA)
Non Fluent/Agrammatic Variant (nfvPPA)
Clinical Manifestations
NfvPPA is a rare, early-onset neurodegenerative syndrome with
a mean age of onset of ∼60 years (17). The duration of survival
is quite variable, ranging from 2 years in cases associated with
amyotrophic lateral sclerosis to about 12 years in cases not
associated with any motor disorder (18, 19).
The hallmark clinical features of nfvPPA are effortful speech
and agrammatism. Effortful speech is characterized by slow,
labored speech production, mainly due to a speech motor
planning deficit, i.e., apraxia of speech (AOS) (20). Speech
sound errors, consisting of distortions, deletions, substitutions,
insertions, or transpositions of speech sounds are present.
Distortions are considered as phonetic errors and are caused by
AOS, while deletions, substitutions, insertions and transpositions
are phonemic errors and can be caused by a motor speech
impairment or a phoneme selection deficit (21, 22). However,
there are some significant challenges in differentiating these two
types of errors clinically, and both studies showing higher rates
of phonetic errors (23, 24) or higher rates of phonemic errors
(21, 22) in nfvPPA patients have been reported. Prosody is
also typically affected in nfvPPA. Dysarthric features often co-
occur with AOS, usually with mixed hypophonic and spastic
features (20). Agrammatism is characterized by short, simple
phrases, and omission of grammatical morphemes. Difficulties
are present in language production (e.g., omission of articles, use
of incorrect morphological endings), as well as in comprehension
(e.g., difficulties in understanding complex syntactic structures,
such as passives and relative clauses) (25). Patients with nfvPPA
often use fewer verbs compared with healthy controls, in part
because verbs play a critical part in syntactically structuring
a sentence. They also have difficulty with verb naming and
comprehension tasks (26).
With the progression of the disease, other cognitive deficits
may emerge, including a decline in attentional resources
and verbal working memory, as well as executive functions,
episodic memory, praxis and behavioral symptoms (27, 28).
General neurological examination is normal early in the disease
course but extrapyramidal signs, and in many cases, a florid
progressive supranuclear palsy syndrome (PSP-s) or corticobasal
syndrome (CBS), can occur later in the disease course (24,
29–34) when the disease advances to SMA and subcortical
regions, which might be due to the underlying FTD-4R
pathology (see section Pathology). In cases in which language
difficulties are very early accompanied by a clear extrapyramidal
syndrome (for example, a generalized rigidity or tremor), the
diagnosis of PPA is excluded. In these cases, even though the
specific criteria for nfvPPA might be fulfilled, the general PPA
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criteria proposed by Mesulam are not fulfilled (12), given the
predominance of the extrapyramidal syndrome and its impact
on daily living activities. Therefore, clinically, these patients are
diagnosed with PSP-s or CBS with speech/language features
(35, 36). Conversely, mild deficits, such as mild limb apraxia or
slowness in fine finger movements, do not exclude a diagnosis
of PPA.
The current clinical criteria (11) for nfvPPA include at least
one of the following core features: (1) Agrammatism in language
production; (2) Effortful, halting speech with inconsistent speech
sound errors and distortions (AOS); and at least 2 of 3
of the following other features: (1) Impaired comprehension
of syntactically complex sentences; (2) Spared single-word
comprehension; (3) Spared object knowledge.
Linguistic/Cognitive Assessment
Spontaneous speech in nfvPPA can be assessed using description
of a picture, such as “The cookie theft” (37), “The picnic scene”
from the Western Aphasia Battery (38), or a picture story
such as “Frog, where are you?” (39). These connected speech
samples may yield information about fluency, grammatical
competence, and motor speech abilities, amongst others (23, 40).
Previous studies have revealed that speech samples in nfvPPA
are characterized speech sound errors, as well as slow rate,
syntactic errors, and reduced complexity (21–23). Specific tests
for the motor speech component, performed by an expert speech
pathologist, are also highly recommended. These may include
articulatory tasks of increasing difficulty, from simple phonation
and production of single syllables (e.g., puh/puh/puh) to more
complex diadochokinetic tasks (e.g., puh/tuh/kuh/), repetition
of multisyllabic words (e.g., impossibility), and finally, sentence
repetition [e.g., (41)].
Motor speech disorders may, in some cases, prevent the
accurate assessment of agrammatism. One approach is to use
sentence production tasks, such as the Northwestern Anagram
Test, which requires to assemble individual word cards into
a meaningful sentence (42). Another approach is to assess
grammatical processing in comprehension, by asking patients to
point to one of two pictures after hearing an auditorily presented
sentence. In this task, accurate decoding of the grammatical
structure of the sentence is required to select the correct picture.
Conversely, in very early stages of disease, written language (such
as a written description of a picture) can often reveal early, mild
grammatical errors. Specific tests for word-comprehension and
object knowledge, functions usually spared in the early phases,
should also be systematically administrated.
Neuroimaging Findings
The left inferior frontal gyrus (pars opercularis) is considered
as the syndrome-specific epicenter in nfvPPA (43, 44). It
is also associated with gray matter (GM) atrophy in the
insula, premotor regions, SMA and striatum (Figure 1) (10,
45, 46). Syntactic processing deficits observed in these patients
are associated with structural and functional abnormalities
in the posterior part of inferior frontal gyrus (47). Some
patients can become mute early in the course of the disease.
This profile is associated with GM atrophy that is more
prominent in the pars opercularis, extending into the left basal
ganglia (48).
A few studies reported that AOS and agrammatism can
occur separately in nfvPPA, affecting different subcomponents
of the same brain network (49). In cases in which AOS presents
as an isolated symptom, the term of “primary progressive
apraxia of speech” has been applied (PPAOS). On one hand,
patients with PPAOS, might show focal imaging abnormalities
in the premotor cortex. On the other hand, patients with
dominant agrammatic deficits show widespread involvement
of premotor, prefrontal, temporal, and parietal lobes, as well
as in the caudate nucleus and the insula (49). Nevertheless,
in the most common presentation of nfvPPA, motor speech
deficits are prevalent, but signs of agrammatism are also
present. Atrophy in these cases includes premotor and posterior
inferior frontal regions, progressing along the aslant tract to
the supplementary motor area (SMA) complex and eventually
to the basal ganglia and supramarginal gyrus (46). nfvPPA
is therefore an example of a network disorder involving
the circuit of regions and connections involved in speech
production.
Diffusion magnetic resonance imaging (MRI) techniques have
shown that the dorsal language pathway of long-range white
matter (WM) fibers connecting frontal, subcortical, and parietal
areas are primarily involved in neurodegeneration in nfvPPA
(46, 50) (Figure 2). This damage appears to be specific to this
variant and is not observed in other PPA variants. WM damage
in the dorsal pathway (superior longitudinal fasciculus) is also
observed (Figure 3) (51–53). Consistently, a recent resting state
fMRI study has demonstrated decreased functional connectivity
between the left inferior frontal gyrus and the posterior middle
temporal gyrus in nfvPPA, even in patients in which the atrophy
is not severe (54).
Longitudinal GM atrophy changes in nfvPPA occur, 1 year
after the first visit, in the left posterior frontal regions (often
comprising inferior middle and superior gyri), supplementary
motor area, insula, striatum, inferior parietal regions, and
underlying WM (43, 55–57). Atrophy progresses to the
supplementary motor complex region through the aslant tract.
This tract is involved in the initiation and execution of
movements, especially articulation. In nfvPPA, its integrity is
associated with the number of distortion errors made by patients
in spontaneous speech as well as with performance in a verbal
fluency task (46, 58).
Pathology
NfvPPA is most commonly associated with a form of FTD-4R
tau (45, 59–65). Other reports indicate TDP-43-A pathology
in nfvPPA (45, 59, 66) and in some cases associated with
progranulin (PGRN) or chromosome 9 open reading frame 72
(C9ORF72) gene mutations (67). Less frequently, AD pathology
has also been reported in nfvPPA (45, 60, 61). However, a recent
study investigating PPA patients with discordant amyloid status
(i.e., nfvPPAwith AD pathology) has suggested that most of these
cases actually present mixed pathology (FTD tau pathology as
primary pathologic diagnosis and AD pathology as contributing
pathologic diagnosis) (68).
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FIGURE 1 | Areas of significant atrophy in a group of patients with nonfluent/agrammatic variant of primary progressive aphasia (nfvPPA) and then subdivided by
pathological subgroups. The main areas of atrophy are mainly in the left inferior frontal gyrus, insula and premotor areas. No significant difference was observed in the
comparison between nfvPPA-tau and nfvPPA-TDP-43 patients in this study. However, greater white matter damage has been reported in nfvPPA-tau cases (69). FWE,
family wise error; 4R-tau, nfvPPA patients with FTD-tau with 4 repeats pathology; PiD, nfvPPA patients with Pick’s disease pathology; TDP-A, nfvPPA patients with
FTD-TDP-43 depositions type A pathology; AD + CBD, nfvPPA patients with Alzheimer’s disease and corticobasal degeneration pathologies; GM, gray matter; WM,
white matter; L , left [from (45), Permission to reproduce have been obtained from the copyright holders of this work].
While progress has been made in understanding the
underlying pathology in nfvPPA, some recent studies have
also begun to characterize nfvPPA patients according to their
underlying pathology. Clinically, it has been hypothesized
that cases with predominant and isolated motor speech
disorders would be associated with tau (24), while predominant
agrammatism could predict TDP-43-A pathology. While similar
GM damage have been observed in nfvPPA-tau and nfvPPA-
TDP patients (Figure 1), greater WM damage has been observed
in nfvPPA-tau cases (45, 69). Recently, further involvement of
temporo-parietal regions beyond GM loss in the frontal lobe has
been detected in a clinically heterogeneous group of TDP-43-A
cases (64).
NfvPPA patients with underlying FTD-4R tau can also
be further divided in nfv-PPA associated with progressive
supranuclear palsy (PSP) and with corticobasal degeneration
(CBD) anatomopathologies (56). At initial presentation,
dysarthria and relatively selective WM atrophy appear typical
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FIGURE 2 | Speech production white matter tracts are shown in healthy controls, nfvPPA, lvPPA, and svPPA patients. Fractional anisotropy (FA) (A) and mean
diffusivity (MD) (B) metrics were evaluated in four speech production tracts (BA44-SMAc, BA44-Putamen, SMAc-Caudate, and BA44-Caudate) and in the inferior
longitudinal fasciculus (ILF). FA is a measure that quantifies the degree to which the diffusion of water molecules in WM fiber bundles is restricted to a specific direction
(a higher FA value is associated with a better structural integrity). MD is a measure that quantifies the average degree of diffusion of water molecules in all directions (a
lower MD value is associated with a better structural integrity). These results suggest that the white matter tracts connecting the speech production network are
selectively damaged in nfvPPA. BA44, Broadmann Area 44; SMAc, Supplementary motor area complex; ILF, inferior longitudinal fasciculus. [from (46), Permission to
reproduce have been obtained from the copyright holders of this work].
FIGURE 3 | Left language-related white matter tracts are shown in healthy controls, nfvPPA, svPPA, and lvPPA patients. Fractional anisotropy (FA) (A) and mean
diffusivity (MD) (B) metrics were evaluated in three tracts: the SLF (dorsal pathway), the ILF and UNC (ventral pathways). FA is a measure that quantifies the degree to
which the diffusion of water molecules in WM fiber bundles is restricted to a specific direction (a higher FA value is associated with a better structural integrity). MD is a
measure that quantifies the average degree of diffusion of water molecules in all directions (a lower MD value is associated with a better structural integrity). In nfvPPA,
the main damage was observed in the dorsal pathway. In svPPA, the two ventral pathways as well as the temporal part of the dorsal pathway was damaged. In lvPPA,
only the temporoparietal part of the dorsal pathway was damaged. SLF, Superior longitudinal fasciculus; ILF: inferior longitudinal fasciculus; UNC: uncinated
fasciculus; FA, fractional anisotropy; MD, mean diffusivity [from (51), Permission to reproduce have been obtained from the copyright holders of this work].
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of nfvPPA-PSP, while greater sentence comprehension deficits
appear typical of nfvPPA-CBD. While these speech/language
differences dissipate at a one-year follow-up, the progression of
atrophy also allow to differentiate the two subgroups (56). In
nfvPPA-PSP, atrophy spreads within the subcortical/brainstem
motor system, which is consistent with greater oculomotors
deficits and swallowing difficulty. In nfvPPA-CBD, atrophy
progresses anteriorly in prefrontal regions, which is thought to




SvPPA is characterized by a progressive and multimodal loss of
semantic knowledge (70). Age at onset is variable, most often
between 55 and 70 years (71). The duration of the disease is
also variable and can range from 2 to 15 years, although patients
typically survive 7–8 years after onset (72, 73). Studies of the
prevalence and incidence of svPPA are relatively limited, but
a recent epidemiology study estimated the prevalence of FTD
at 10.8/100,000, with svPPA accounting for approximately one-
third of these cases (74).
These patients progressively lose the meaning of words,
and they usually present with severe, progressive anomia, and
markedly impaired comprehension of single words (11, 30). In
earlier stages, the loss of meaning of words, and subsequently,
naming and single-word comprehension deficits, are more
prominent for low frequency/familiarity items (e.g., “rhinoceros”
vs. “dog”) (75). Often, the patients replace less frequent words
with more familiar ones, typically using the superordinate
category (e.g., “animal” for “cat”). Another salient aspect of the
syndrome is the production of semantic paraphasias in naming
(e.g., “brush” for “comb”). Anomia can also be observed in
spontaneous speech that is often empty and not very informative
(23, 76). In the early stages, inability to comprehend low-
familiarity words can be the only symptom accompanying
anomia, and patients frequently ask for the meaning of words.
The progression of semantic deficits leads to impaired object
recognition affecting all sensory modalities, including vision,
touch, olfaction, and gustation (7, 70) [e.g., visual agnosia; (73)].
The ability to correctly identify objects is strongly influenced
by familiarity with the object (e.g., “fork” is more familiar than
“compass”) (77). Additionally, individuals with svPPA appear to
have disproportionate difficulty understanding concrete concepts
relative to abstract concepts (78–80). Rarely, cases have been
described with greater, or even selective, deficits for people (81)
and animals (82). Some patients demonstrate impairment in the
recognition of faces, which stems from a loss of person knowledge
(83) that is also familiarity-dependent (84).
In contrast, episodic memory is relatively preserved in svPPA,
especially when tasks with minimal conceptual loading are
used (85, 86). The intact performance on traditional non-
conceptually loaded episodic memory tasks converges with the
performance of svPPA patients on autobiographical memory
tasks. Patients typically show relatively preserved recollection of
recent autobiographical memory in the context of poorer remote
autobiographical memory (known as the reverse temporal
gradient or step-function), reflecting increased semanticisation
of past events (87, 88). SvPPA patients have also difficulties in
episodic future thinking (89, 90).
The loss of word meaning is also apparent in reading. Patients
do not recognize words as whole entities, but rather adopt
a phonological strategy, deriving pronunciations using letter-
sound conversion. As a result, irregular words are pronounced
as if they are regular (“yatsht” for “yacht”), a phenomenon
called surface dyslexia (91, 92). A similar pattern of selective
impairment for irregular words is observed in spelling (surface
dysgraphia).
Behavioral abnormalities are typically present in mid-late
phases, including disinhibition, irritability, and food taste
changes (e.g., preference for sweet foods). Lack of empathy,
mental inflexibility, and compulsions - including clockwatching
and intense interest in jigsaws—are also frequently noted (93–
95). Almost 50% of svPPA patients report experiencing somatic
symptom disorder as misidentification and preoccupation with
normal bodily sensations such as hunger, bladder filling,
borborygmi, rhinorrhea, and reflux; excessive concern over
the incompletely understood meaning or source of pain or
other symptoms; and Cotard syndrome or the delusion that
unidentified somatic symptoms signify death or deterioration
(96). This inability to read and name somatic sensations,
or “alexisomia,” results in disproportionate and persistent
concern about somatic sensations with consequent significant
disability (96).
It has been demonstrated that non-right-handedness is
overrepresented in svPPA patients, at nearly twice the prevalence
of the general population. Left-handedness has been described as
a proxy for atypical brain hemispheric lateralization (97).
The current diagnostic guidelines (11) identify anomia
and single-word comprehension deficits as core features, both
essential for diagnosis. At least 3 of the following other diagnostic
features must also be present: (1) impaired object knowledge,
particularly for low- frequency or low-familiarity items; (2)
surface dyslexia or dysgraphia; (3) spared repetition; and 4.
spared speech production (grammar and motor speech).
Linguistic/Cognitive Assessment
Language assessment of svPPA includes tests of confrontation
naming, in which the patient is asked to retrieve the word
in response to a picture [e.g., the Boston Naming test (98)].
Object and person knowledge are also examined using tests
of semantic associations, gesture-object matching, and sound-
picture matching tasks. The popular Pyramids and Palm Trees
Test (99) is a semantic association task that measures the
capacity to access detailed semantic information about words
and pictures necessary for the identification of the relationships
that conceptually link two perceptually and functionally distinct
entities. The loss of concepts can be also tested using other types
of stimuli, including sounds, foods, and odors. Famous faces and
buildings naming tasks, as well as semantic knowledge tasks are
also very sensitive with svPPA patients (100).
Reading and spelling of regular and irregular words are
also tested in order to identify surface dyslexia and dysgraphia.
Spontaneous speech should also be assessed in svPPA. Differently
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from nfvPPA, the spontaneous speech should not present AOS
and the syntactic structure should be preserved. On the other
side, svPPA present increased use of highly familiar words,
anomia characterized by long pauses and use of general words
(such as “thing”) for identifying the items displayed on the image.
Episodic memory tests based on non-linguistic stimuli (such
as Rey Complex Figure) should be administered to exclude the
presence of major episodic memory deficits, especially at early
stages of the disease. Repetition and syntactic comprehension
tests should be evaluated as an exclusion criterion.
Neuroimaging Findings
The anterior temporal lobes show bilateral atrophy and
hypoperfusion in svPPA and is considered as the syndrome-
specific epicenter (45, 101–104) (Figure 4). This focal anatomical
damage makes neuroimaging a complementary tool in the
diagnostic process for this PPA variant (105). The damage is
usually greater in the left hemisphere at first stages of the disease
(30). Typical semantic impairment is associated with greater
left-sided anterior temporal atrophy/hypometabolism (106, 107),
naming difficulties are correlated with superior portions of the
left temporal pole (108), and finally, loss of person knowledge
and behavioral changes are associated with more extensive right
temporal atrophy (109, 110). Atrophy of the hippocampus has
been reported mainly involving the anterior portion, which is
connected to the semantic memory system (111). On the other
hand, the posterior portion, mainly connected to the episodic
memory system, would be relatively spared (112). This pattern
of hippocampal atrophy would explain the dissociation between
semantic and episodic memory deficits in svPPA population.
Microstructural studies of WM integrity have shown damage
in the ventral tracts that connect the temporal lobe to the
occipital lobe and to the orbitofrontal cortex, with left side
predominance (Figure 3) (51). The dorsal frontoparietal tracts
that do not involve the temporal lobes are spared bilaterally,
except for the temporal segment of the dorsal pathway (Figure 3)
(51, 113, 114). This pattern is highly left lateralized compared
with behavioral variant of fronto-temporal dementia which has a
right predominance (115). During the progression of the disease,
right-hemisphere WM bundles, in particular the uncinate, are
preferentially damaged (116).
At the functional level, svPPA patients manifest extensive
reduced anterior temporal lobe connectivity with primary and
modality-selective cortices (117, 118). The longitudinal pattern of
atrophy can be predicted by functionalMRI connectivity between
the temporal pole and the rest of the brain following connectional
pathways within a large-scale network (119).
As the disease progresses, the atrophy involves the ventral and
lateral temporal regions, as well as the contralateral temporal
lobe and frontal regions (57, 120, 121). Beyond the specific
metabolic signatures, additional dysfunctional patterns in the
early stages can predict clinical progression: svPPA patients who
FIGURE 4 | (A) Areas of significant atrophy in a group of patients with semantic variant of primary progressive aphasia (svPPA) and subdivided by pathological
subgroups. The main areas of atrophy are in the bilateral anterior temporal lobes, more predominantly in the left hemisphere. (B) Areas of significant atrophy in svPPA
patients with FTD tau pathology, in comparison to those with TDP-43 pathology. These patients present greater atrophy of frontotemporal cortex (medial anterior
temporal lobe, orbitofrontal cortex, anterior cingulate cortex), basal ganglia and connecting white matter structures. FWE , family wise error; TDP-C, svPPA patients
with FTD-TDP-43 depositions type C pathology; TDP-C+ tau nos, svPPA patients with FTD-TDP-43 depositions type C and tau pathology not otherwise specified;
PiD, svPPA patients with Pick’s disease pathology; GGT, svPPA patients with globular glial tauopathy pathology; L , left; R , right; GM, gray matter; WM, white matter
[from (45), Permission to reproduce have been obtained from the copyright holders of this work].
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present with extended bilateral patterns at baseline eventually
develop behavioral disorders and a dysexecutive syndrome at
follow-up (122).
Pathology
SvPPA is nearly always associated with underlying TDP-
43-C pathological aggregates (75–100% in clinicopathological
correlation series), and for the remainder of patients, most often
with FTD tau (45, 60, 62, 66, 123–126). Rarely, AD pathology
has also been reported in svPPA (60, 126), although a recent
study has shown that most svPPA cases with AD pathology also
present TDP-43-C pathology (68). In comparison to patients with
TDP-43 pathology, those with FTD tau pathology present greater
atrophy of frontotemporal cortex (medial anterior temporal lobe,
orbitofrontal cortex, anterior cingulate cortex), basal ganglia and
connecting WM bundles (Figure 4) (45). Interestingly, svPPA
patients and PGRN mutation carriers are both characterized by
underlying TDP-43 aggregation. In some cases, patients with
PGRN mutations can develop aphasia with semantic deficits
(127). However, familial forms of pure svPPA have not been
reported. In both svPPA patients and PGRN mutation carriers,
an increased prevalence of specific and related autoimmune
diseases has been found, suggesting a unique pattern of systemic
inflammation (128). Very rarely, mutations of the C9ORF72 gene
have also been described in svPPA (129).
Recent studies have tried to identify FTD pathological
subtypes with the help of cerebrospinal fluid (CSF) biomarkers.
Increased neurofilament light chain (NfL) levels in the CSF, which
are associated with neuronal and axonal degeneration, have been
reported in patients with neurodegenerative diseases, and more




LvPPA has been more recently characterized (10, 131) as a
distinct form of PPA, and little is known about its age at onset and
disease survival. As with the other variants of PPA, the logopenic
variant is considered an early onset form of dementia (132).
Patients with lvPPA typically present with word finding
difficulty, along with sentence repetition deficits and, as
the disease progresses, impaired sentence comprehension.
Phonological impairments and, specifically, a phonological
short-term memory deficit, have been suggested to be the core
of the syndrome (131). In accordance with this interpretation,
repetition and comprehension of single words remaining largely
spared.
Prior to the current consensus criteria for diagnosis, lvPPA
was often diagnosed as nfvPPA (60). Both variants can present
with slow speech, frequent word-finding pauses and speech
sound errors. However, patients with nfvPPA have slower speech
and, conversely, those with lvPPA do not present with severe
agrammatism and the distorted, effortful speech production
of AOS. Speech sound errors are usually phonemic, but not
phonetic (21, 23). Confrontation naming is often impaired,
albeit at a lesser degree if compared to svPPA. Phonological
paraphasias can occur in spontaneous speech and confrontation
naming.
Usually later in the disease, episodic memory impairment (62)
is often present, even though the lexical retrieval impairment
observed in lvPPA patients contributes to verbal episodic
memory performance (133, 134). Longitudinal studies have
shown that cognitive decline is faster in lvPPA in comparison
to other variants, and that this decline is not restricted to
language functioning (135). In lvPPA patients, a more accelerated
decline was also observed in visuospatial abilities (136), in
memory and in attention (135). This finding has been associated
with the underlying AD pathology (see section Pathology).
Poor calculation abilities (137) and limb apraxia can also
occur (10). Apathy, anxiety, irritability, and agitation are often
reported (138).
Recent studies have revealed that in comparison to the
general population, PPA patients report higher rates of learning
disabilities (and more specifically developmental dyslexia) in
their early phases of life (139), and that dyslexia susceptibility
genes influence brain atrophy in PPA (140). Further reports
suggested that the frequency was specifically higher in lvPPA
patients in comparison to the other variants, and that in
these patients, learning disability is associated with earlier
onset of disease, more isolated language symptoms, and
more focal pattern of left posterior temporoparietal atrophy
(97). Developmental dyslexia, which is the most common
developmental language learning disability, can manifest with
phonological disturbances and posterior temporal involvement,
similarly to lvPPA. In the framework of network vulnerability
hypothesis, learning disability might confer susceptibility of
language network to early-onset, focal AD pathology such
as lvPPA (97). However, further research is needed to
confirm the higher frequency of developmental dyslexia in
lvPPA specifically, since another study provided conflicting
results (141).
Criteria for lvPPA (11) require that both of the following
core features must be present: impaired single-word retrieval in
spontaneous speech and naming along with impaired repetition
of sentences and phrases. At least 3 of the following other features
must be present: (1) phonological errors in spontaneous speech
and naming; (2) spared single-word comprehension and object
knowledge; (3) spared motor speech; and (4) absence of frank
agrammatism.
Linguistic/Cognitive Assessment
The evaluation of spontaneous speech is essential in order
to appreciate lvPPA patients’ anomia and can be done using
description of a picture as previously described. In such tasks,
anomia may manifest in phonological paraphasias, hesitations,
and frequent pauses for word-finding. Language assessment of
lvPPA also includes confrontation naming tasks such as the
BostonNaming Test (98). Oral repetition of words, pseudowords,
phrases, and sentences, are usually administered in order to show
the dissociation between preserved single word repetition, in
opposition to the greater impairment for sentences and phrases.
Moreover, phonological errors are often appreciated (142). Tests
for sentence comprehension consist of matching orally presented
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sentences to pictures. Patients with nfvPPA also fail on these
types of tests because of the effect of grammatical complexity,
whereas patients with lvPPA fail because of the effects of length
and frequency.
Reading and spelling tests reveal phonological errors as well
as difficulty with pseudowords, which rely upon phonological
processing (91). LvPPA patients also show difficulties in verbal
working memory tests, such as the digit span from the Weschler
Adult Intelligence Scale (48, 143). Single-word comprehension,
motor speech and agrammatism should be evaluated as exclusion
criteria. Recent studies have suggested that non-linguistic
features, namely visuospatial functioning (136), episodicmemory
and emotion processing (144), are also helpful in the differential
diagnosis of lvPPA in comparison to the other variants (and
specially with nfvPPA).
Neuroimaging Findings
Anatomical damage in lvPPA is typically located in posterior
superior temporal andmiddle temporal gyri as well as the inferior
parietal lobule (10, 45). This pattern of atrophy is consistent
with the classical anatomical model of the phonological loop
(131). This neurodegenerative pattern is very similar to the
one observed in early-onset AD (132). Naming difficulties are
correlated with the left posterior temporal cortex (108). Recently,
a model of the progression of atrophy in lvPPA has been
suggested, showing that atrophy progresses from the disease
epicenter (left posterior superior and middle temporal gyri) to
ipsilateral parietal and frontal lobes and contralateral temporal
lobe (145).
WM loss in association tracts in the left hemisphere has been
detected (146), mainly in parietal fibers linking the parietal with
frontal and posterior temporal regions (Figure 3) (51). A recent
longitudinal study also suggested that early WM changes in
lvPPA can be observed in the left posterior inferior longitudinal
fasciculus, and that these changes become widespread over a year
of progression of the disease, also affecting the anterior inferior
longitudinal fasciculus, the uncinate fasciculus and the superior
longitudinal fasciculus (116).
In terms of functional connectivity, the working memory
network (frontal regions, inferior parietal lobule, superior,
and middle temporal gyri) and language network (posterior
superior temporal gyrus and inferior frontal lobe) have been
shown to be altered in lvPPA patients in a resting-state fMRI
study (147).
Pathology
LvPPA is most often caused by AD pathology (45, 60, 65),
in as many as 95% of cases (68). It is considered one of the
possible focal and early onset presentations of AD (62, 107,
132), even if other pathological profiles have been more rarely
described, including Lewy body dementia (148), TDP-43, and
tau (60).
Cerebro-spinal fluid examination (149) and molecular
imaging techniques such as PET with Pittsburgh Compound B
(PIB) (107), a ligand for the amyloid, have shown the presence of
amyloid in these individuals. However, in comparison to typical
AD patients, lvPPA patients with AD pathology show more
significant hypoperfusion in the left superior temporal gyrus
(Figure 5) (149).
Some authors have demonstrated the coexistence of AD
pathology and argyrophilic thorny astrocyte clusters (ATAC),
intensely tau immunoreactive, in the fronto-temporoparietal
cortex and subcortical regions (150). They suggest that they
might represent a marker of a process responsible for the
prominent focal clinical manifestations in lvPPA (150). Finally, a
clinical syndrome with lvPPA features but also with more global
features may be pre-dominantly linked to mutations in the GRN
gene (151).
PPA Unclassifiable
In addition to the three most common variants, the 2011
consensus criteria also suggest that a minority of patients might
be unclassifiable (11). It might be the case in patients who present
FIGURE 5 | Comparison of areas of hypoperfusion between groups of lvPPA patients with AD pathology, lvPPA patients without AD pathology and typical AD
patients. LvPPA patients present significant hypoperfusion in the left temporal-parietal junction, affecting larger portions of the temporal cortex in the lvPPA patients
with AD pathology. In comparison to typical AD patients, lvPPA patients with AD pathology show more significant hypoperfusion in the left superior temporal gyrus.
LPA, lvPPA; LPA-, lvPPA patients without AD pathology; LPA+, lvPPA patients with AD pathology; AD, Alzheimer’s disease [from (149), Permission to reproduce have
been obtained from the copyright holders of this work].
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for a long time with a single language symptom or in patients
who present mixed features. It was further suggested that with the
progression of the disease, these patients’ profiles might become
clearer.
A few studies have directly investigated the extent to
which the 2011 consensus criteria cover the diversity of
PPA cases. While some of them found that most patients
could be classified within the three suggested variants (60,
61, 68, 152), others reported higher percentage (20–41%)
of unclassifiable PPA patients (153–155). One of the main
difficulty described by these last authors is related to patients
who present with a single isolated language symptom, thus
fulfilling the root criteria for PPA, but not the criteria for
any of the variants. The most often reported cases are the
ones who present with isolated anomia, without impaired
repetition of single word, sentences and phrases (therefore only
partially fulfilling criteria for lvPPA). Another main difficulty
reported is related to patients who present a mixed profile,
thus fulfilling the criteria for more than one of the variants.
Patients presenting both sentence repetition impairments and
agrammatism (therefore fulfilling criteria for both lvPPA and
nfvPPA), as well as patients presenting both agrammatism and
semantic impairments (fulfilling criteria for both nfvPPA and
svPPA) have been observed.
Many factors could be associated with a varying proportion
of unclassifiable PPA cases. First, the potential inclusion of
genetic forms of PPA in studies might lead to higher number
of mixed profiles. For example, it has been suggested that
PGRN mutation carriers might present with a lvPPA and
nfvPPA mixed profile (156). Furthermore, there is likely a high
heterogeneity in tests and cutoffs used in the diagnosis of PPA
across different clinical and research sites. There is a need for
a use of sensitive and specific tests, and some authors have
recently published assessment batteries specifically designed for
the assessment of PPAs (157, 158). Most importantly, apparently
similar symptoms might be due to distinct underlying causes
between PPA variants, and this should be considered in tests
selection and interpretation. For example, some studies have
suggested that repetition deficits might be of different nature in
lvPPA and nfvPPA. In lvPPA, they might be due to a disruption
of the store component of the phonological loop, while in
nfvPPA, impairments in speech motor planning might affect
the subvocal rehearsal component of the phonological loop
(159). This has also been investigated regarding the overlapping
naming impairments in svPPA and lvPPA, which are thought
to be respectively due to a semantic impairment vs. a lexical
access deficit (160, 161). Finally, more prospective studies
investigating the classification of PPA patients are needed, since
retrospective studies are more likely to not have had adequate
or complete test batteries to apply the current criteria (68).
Nonetheless, even though significant progress was made in the
recent years in the understanding of PPA, these studies illustrate
that there are still controversies in the diagnosis of PPA and
the above-mentioned issues will need to be clarified in the next
years.
CONCLUSION
In summary, each variant of PPA (nfv-, sv-,
and lv-PPA) is characterized by a prototypic
neurolinguistic/neuropsychological, neuroimaging and
neuropathological profile. The effervescence of PPA as a
research field in the recent years has allowed for key discoveries
in each of these domains. In terms of clinical advancements,
recent studies have allowed a better characterization and
differentiation of PPA patients based on both their linguistic
and non-linguistic profiles. In terms of neuroimaging,
techniques such as diffusion imaging and resting-state
fMRI, as well as multimodal studies, have allowed a deeper
understanding of the impact of PPA on structural and
functional connectivity alterations beyond the well-defined
pattern of regional gray matter atrophy. Finally, in terms
of pathology/genetics, despite significant advances, clinico-
pathological correspondence is still far to be absolute. The
improved characterization of PPA has the potential to have
a positive impact on the management of individual patients.
It can help to better direct patients toward appropriate
therapeutic and behavioral intervention, as well as to provide
adequate counseling of families and caregivers (162). Improved
reliability of diagnoses and the development of reliable in vivo
biomarkers for underlying neuropathology will be increasingly
important as trials for etiology-specific treatments become
available.
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